View More View Less
  • 1 Semmelweis University Clinical Microbiology Diagnostic Laboratory, Institute of Laboratory Medicine Budapest Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

The incidence of Candida bloodstream infection (BSI) has been on the rise in several countries worldwide. Species distribution is changing; an increase in the percentage of non-albicans species, mainly fluconazole non-susceptible C. glabrata was reported. Existing microbiology diagnostic methods lack sensitivity, and new methods need to be developed or further evaluation for routine application is necessary. Although reliable, standardized methods for antifungal susceptibility testing are available, the determination of clinical breakpoints remains challenging. Correct species identification is important and provides information on the intrinsic susceptibility profile of the isolate. Currently, acquired resistance in clinical Candida isolates is rare, but reports indicate that it could be an issue in the future. The role of the clinical microbiology laboratory is to isolate and correctly identify the infective agent and provide relevant and reliable susceptibility data as soon as possible to guide antifungal therapy.

  • Wisplinghoff, H., Bischoff, T., Tallent, S.M., Seifert, H., Wenzel, R.P., Edmond, M.B.: Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39, 309–317 (2004).

    Edmond MB , 'Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study ' (2004 ) 39 Clin Infect Dis : 309 -317.

    • Search Google Scholar
  • Sandven, P., Bevanger, L., Digranes, A., Haukland, H.H., Mannsåker, T., Gaustad, P., and the Norwegian Yeast Study Group: Candidemia in Norway (1991 to 2003): Results from a nationwide study. J Clin Microbiol 44(6), 1977 (2006).

    Gaustad P , 'Candidemia in Norway (1991 to 2003): Results from a nationwide study ' (2006 ) 44 J Clin Microbiol : 1977 -.

    • Search Google Scholar
  • Puig-Asensio, M., Padilla, B., Garnacho-Montero, J., Zaragoza, O., Aguado, J.M., Zaragoza, R., Montejo, M., Muñoz, P., Ruiz-Camps, I., Cuenca-Estrella, M., Almirante, B.: Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect 20(4), 245–254 (2014).

    Almirante B , 'Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain ' (2014 ) 20 Clin Microbiol Infect : 245 -254.

    • Search Google Scholar
  • Arendrup, M.C., Bruun, B., Christensen, J.J., Fuursted, K., Johansen, H.K., Kjaeldgaard, P., Knudsen, J.D., Kristensen, L., Møller, J., Nielsen, L., Rosenvinge, F.S., Røder, B., Schønheyder, H.C., Thomsen, M.K., Truberg, K.: National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol 49, 325–334 (2011).

    Truberg K , 'National surveillance of fungemia in Denmark (2004 to 2009) ' (2011 ) 49 J Clin Microbiol : 325 -334.

    • Search Google Scholar
  • Kuhns, M., Rosenberger, A., Bader, O., Reichard, U., Gross, U., Weig, M.: [Incidence of candidaemia following abdominal surgery in German hospitals]. Zentralbl Chir 2013 Nov 15. (in German)

    Weig M [ , '', in Zentralbl Chir , (2013 ) -.

  • Bassetti, M., Righi, E., Costa, A., Fasce, R., Molinari, M.P., Rosso, R., Pallavicini, F.B., Viscoli, C.: Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6, 21 (2006).

    Viscoli C , 'Epidemiological trends in nosocomial candidemia in intensive care ' (2006 ) 6 BMC Infect Dis : 21 -.

    • Search Google Scholar
  • Pfaller, M.A., Neofytos, D., Diekema, D., Azie, N., Meier-Kriesche, H.U., Quan, S.P., Horn, D.: Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008. Diagn Microbiol Infect Dis 74(4), 323–331 (2012).

    Horn D , 'Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008 ' (2012 ) 74 Diagn Microbiol Infect Dis : 323 -331.

    • Search Google Scholar
  • Das, I., Nightingale, P., Patel, M., Jumaa, P.: Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK. Int J Infect Dis 15, 759–763 (2011).

    Jumaa P , 'Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK ' (2011 ) 15 Int J Infect Dis : 759 -763.

    • Search Google Scholar
  • Alexander, B.D., Johnson, M.D., Pfeiffer, C.D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S.A., Perlin, D.S., Pfaller, M.A.: Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56(12), 1724–1732 (2013).

    Pfaller MA , 'Increasing echinocandin resistance in Candida glabrata: Clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations ' (2013 ) 56 Clin Infect Dis : 1724 -1732.

    • Search Google Scholar
  • Cuenca-Estrella, M., Verweij, P.E., Arendrup, M.C., Arikan-Akdagli, S., Bille, J., Donnelly, J.P., Jensen, H.E., Lass-Flörl, C., Richardson, M.D., Akova, M., Bassetti, M., Calandra, T., Castagnola, E., Cornely, O.A., Garbino, J., Groll, A.H., Herbrecht, R., Hope, W.W., Kullberg, B.J., Lortholary, O., Meersseman, W., Petrikkos, G., Roilides, E., Viscoli, C., Ullmann, A.J.: ESCMID guideline for the diagnosis and management of Candida diseases 2012: Diagnostic procedures. Clin Microbiol Infect 18(Suppl. 7), 9–18 (2012).

    Ullmann AJ , 'ESCMID guideline for the diagnosis and management of Candida diseases 2012: Diagnostic procedures ' (2012 ) 18 Clin Microbiol Infect : 9 -18.

    • Search Google Scholar
  • Arendrup, M.C.: Candida and candidaemia. Susceptibility and epidemiology. Dan Med J 60(11), B4698 (2013).

    Arendrup MC , 'Candida and candidaemia. Susceptibility and epidemiology ' (2013 ) 60 Dan Med J : B4698 -.

    • Search Google Scholar
  • Ruhnke, M., Rickerts, V., Cornely, O.A., Buchheidt, D., Glöckner, A., Heinz, W., Höhl, R., Horré, R., Karthaus, M., Kujath, P., Willinger, B., Presterl, E., Rath, P., Ritter, J., Glasmacher, A., Lass-Flörl, C., Groll, A.H.: Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses 54(4), 279–310 (2011).

    Groll AH , 'Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy ' (2011 ) 54 Mycoses : 279 -310.

    • Search Google Scholar
  • Garey, K.W., Rege, M., Pai, M.P., Mingo, D.E., Suda, K.J., Turpin, R.S., Bearden, D.T.: Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study. Clin Infect Dis 43, 25–31 (2006).

    Bearden DT , 'Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study ' (2006 ) 43 Clin Infect Dis : 25 -31.

    • Search Google Scholar
  • Morrell, M., Fraser, V.J., Kollef, M.H.: Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality. Antimicrob Agents Chemother 49, 3640–3645 (2005).

    Kollef MH , 'Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality ' (2005 ) 49 Antimicrob Agents Chemother : 3640 -3645.

    • Search Google Scholar
  • Fortún, J., Martín-Davila, P., Gomez-García de la Pedrosa, E., Pintado, V., Cobo, J., Fresco, G., Meije, Y., Ros, L., Alvarez, M.E., Luengo, J., Agundez, M., Belso, A., Sanchez-Sousa, A., Loza, E., Moreno, S.: Emerging trends in candidemia: A higher incidence but a similar outcome. J Infect 65(1), 64–70 (2012).

    Moreno S , 'Emerging trends in candidemia: A higher incidence but a similar outcome ' (2012 ) 65 J Infect : 64 -70.

    • Search Google Scholar
  • Pittet, D., Monod, M., Suter, P.M., Frenk, E., Auckenthaler, R.: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220, 751–758 (1994).

    Auckenthaler R , 'Candida colonization and subsequent infections in critically ill surgical patients ' (1994 ) 220 Ann Surg : 751 -758.

    • Search Google Scholar
  • Posteraro, B., De Pascale, G., Tumbarello, M., Torelli, R., Pennisi, M.A., Bello, G., Maviglia, R., Fadda, G., Sanguinetti, M., Antonelli, M.: Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1-3)-β-D-glucan assay, Candida score, and colonization index. Crit Care 15, R249 (2011).

    Antonelli M , 'Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1-3)-β-D-glucan assay, Candida score, and colonization index ' (2011 ) 15 Crit Care : R249 -.

    • Search Google Scholar
  • Wallet, F., Nseir, S., Baumann, L., Herwegh, S., Sendid, B., Boulo, M., Roussel-Delvallez, M., Durocher, A.V., Courcol, R.J.: Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin Microbiol Infect 16, 774–779 (2010).

    Courcol RJ , 'Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood ' (2010 ) 16 Clin Microbiol Infect : 774 -779.

    • Search Google Scholar
  • Avni, T., Leibovici, L., Paul, M.: PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol 49, 665–670 (2011)

    Paul M , 'PCR diagnosis of invasive candidiasis: systematic review and meta-analysis ' (2011 ) 49 J Clin Microbiol : 665 -670.

    • Search Google Scholar
  • Hii, I.M., Chang, H.L., Lin, L.C., Lee, Y.L., Liu, Y.M., Liu, C.E., Chen, C.H., Cheng, Y.R., Chang, C.Y.: Changing epidemiology of candidemia in a medical center in middle Taiwan. J Microbiol Immun Infect S1684-1182(13)00162-X (2013).

    Chang CY , '', in J Microbiol Immun Infect , (2013 ) -.

  • Wisplinghoff, H., Ebbersa, J., Geurtza, L., Stefanika, D., Major, Y., Edmond, M.B., Wenzel, R.P., Seifert, H.: Nosocomial bloodstream infections due to Candida spp. in the USA: Species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents 43(1), 78–81 (2014).

    Seifert H , 'Nosocomial bloodstream infections due to Candida spp. in the USA: Species distribution, clinical features and antifungal susceptibilities ' (2014 ) 43 Int J Antimicrob Agents : 78 -81.

    • Search Google Scholar
  • Bassetti, M., Ansaldi, F., Nicolini, L., Malfatto, E., Molinari, M.P., Mussap, M., Rebesco, B., Pallavicini, F.B., Icardi, G., Viscoli, C.: Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J Antimicrob Chemother 64, 625–629 (2009).

    Viscoli C , 'Incidence of candidaemia and relationship with fluconazole use in an intensive care unit ' (2009 ) 64 J Antimicrob Chemother : 625 -629.

    • Search Google Scholar
  • Borman, A.M., Petch, R., Linton, C.J., Palmer, M.D., Bridge, P.D., Johnson, E.M.: Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J Clin Microbiol 46(3), 933 (2008).

    Johnson EM , 'Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents ' (2008 ) 46 J Clin Microbiol : 933 -.

    • Search Google Scholar
  • Jensen, R.H., Arendrup, M.C.: Candida palmioleophila: Characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species. J Clin Microbiol 49(2), 549–556 (2011).

    Arendrup MC , 'Candida palmioleophila: Characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species ' (2011 ) 49 J Clin Microbiol : 549 -556.

    • Search Google Scholar
  • Shin, J.H., Kee, S.J., Shin, M.G., Kim, S.H., Shin, D.H., Lee, S.K., Suh, S.P., Ryang, D.W.: Biofilm production by isolates of Candida species recovered from nonneutropenic patients: Comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 40(4), 1244–1248 (2002).

    Ryang DW , 'Biofilm production by isolates of Candida species recovered from nonneutropenic patients: Comparison of bloodstream isolates with isolates from other sources ' (2002 ) 40 J Clin Microbiol : 1244 -1248.

    • Search Google Scholar
  • Tumbarello, M., Fiori, B., Trecarichi, E.M., Posteraro, P., Losito, A.R., De Luca, A., Sanguinetti, M., Fadda, G., Cauda, R., Posteraro, B.: Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital. PLos One 7(3), e33705 (2012).

    Posteraro B , 'Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital ' (2012 ) 7 PLos One : e33705 -.

    • Search Google Scholar
  • Tumbarello, M., Posteraro, B., Trecarichi, E.M., Fiori, B., Rossi, M., Porta, R., de Gaetano Donati, K., La Sorda, M., Spanu, T., Fadda, G., Cauda, R., Sanguinetti, M.: Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 45(6), 1843–1850 (2007).

    Sanguinetti M , 'Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia ' (2007 ) 45 J Clin Microbiol : 1843 -1850.

    • Search Google Scholar
  • Kuhn, D.M., George, T., Chandra, J., Mukherjee, P.K., Ghannoum, M.A.: Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46(6), 1773–1780 (2002).

    Ghannoum MA , 'Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins ' (2002 ) 46 Antimicrob Agents Chemother : 1773 -1780.

    • Search Google Scholar
  • Pfaller, M.A., Castanheira, M., Messer, S.A., Moet, G.J., Jones, R.N.: Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009). Diagn Microbiol Infect Dis 68(3), 278–283 (2010).

    Jones RN , 'Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009) ' (2010 ) 68 Diagn Microbiol Infect Dis : 278 -283.

    • Search Google Scholar
  • Krogh-Madsen, M., Arendrup, M.C., Heslet, L., Knudsen, J.D.: Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. Clin Infect Dis 42, 938–944 (2006).

    Knudsen JD , 'Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient ' (2006 ) 42 Clin Infect Dis : 938 -944.

    • Search Google Scholar
  • Forastiero, A., Mesa-Arango, A.C., Alastruey-Izquierdo, A., Alcazar-Fuoli, L., Bernal-Martinez, L., Pelaez, T., Lopez, J.F., Grimalt, J.O., Gomez-Lopez, A., Cuesta, I., Zaragoza, O., Mellado, E.: Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications. Antimicrob Agents Chemother 57, 4769–4781 (2013).

    Mellado E , 'Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications ' (2013 ) 57 Antimicrob Agents Chemother : 4769 -4781.

    • Search Google Scholar
  • M27-A3 Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard—third edition. STANDARD by Clinical and Laboratory Standards Institute, 2008.

  • Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST): EUCAST Definitive Document EDef 7.1: Method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 14, 398–405 (2008).

    'EUCAST Definitive Document EDef 7.1: Method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts ' (2008 ) 14 Clin Microbiol Infect : 398 -405.

    • Search Google Scholar
  • Sanglard, D., Odds, F.C.: Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2, 73–85 (2002).

    Odds FC , 'Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences ' (2002 ) 2 Lancet Infect Dis : 73 -85.

    • Search Google Scholar
  • Kuse, E.R., Chetchotisakd, P., da Cunha, C.A., Ruhnke, M., Barrios, C., Raghunadharao, D., Sekhon, J.S., Freire, A., Ramasubramanian, V., Demeyer, I., Nucci, M., Leelarasamee, A., Jacobs, F., Decruyenaere, J., Pittet, D., Ullmann, A.J., Ostrosky-Zeichner, L., Lortholary, O., Koblinger, S., Diekmann-Berndt, H., Cornely, O.A.: Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet 369, 1519–1527 (2007).

    Cornely OA , 'Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial ' (2007 ) 369 Lancet : 1519 -1527.

    • Search Google Scholar
  • Reboli, A.C., Rotstein, C., Pappas, P.G., Chapman, S.W., Kett, D.H., Kumar, D., Betts, R., Wible, M., Goldstein, B.P., Schranz, J., Krause, D.S., Walsh, T.J: Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356, 2472–2482 (2007).

    Walsh TJ , 'Anidulafungin versus fluconazole for invasive candidiasis ' (2007 ) 356 N Engl J Med : 2472 -2482.

    • Search Google Scholar
  • Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A.L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., Perfect, J.: Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347, 2020–2029 (2002).

    Perfect J , 'Comparison of caspofungin and amphotericin B for invasive candidiasis ' (2002 ) 347 N Engl J Med : 2020 -2029.

    • Search Google Scholar
  • Kabbara, N., Lacroix, C., Peffault de Latour, R., Socie, G., Ghannoum, M., Ribaud, P.: Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy. Haematologica 93, 639–640 (2008).

    Ribaud P , 'Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy ' (2008 ) 93 Haematologica : 639 -640.

    • Search Google Scholar
  • Pfeiffer, C.D., Garcia-Effron, G., Zaas, A.K., Perfect, J.R., Perlin, D.S., Alexander, B.D.: Breakthrough invasive candidiasis on micafungin. J Clin Microbiol 48, 2373–2380 (2010).

    Alexander BD , 'Breakthrough invasive candidiasis on micafungin ' (2010 ) 48 J Clin Microbiol : 2373 -2380.

    • Search Google Scholar
  • Cornely, O.A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B.J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M.C., Arikan-Akdagli, S., Bille, J., Castagnola, E., Cuenca-Estrella, M., Donnelly, J.P., Groll, A.H., Herbrecht, R., Hope, W.W., Jensen, H.E., Lass-Flörl, C., Petrikkos, G., Richardson, M.D., Roilides, E., Verweij, P.E., Viscoli, C., Ullmann, A.J.: ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl 7), 19–37 (2012).

    Ullmann AJ , 'ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients ' (2012 ) 18 Clin Microbiol Infect : 19 -37.

    • Search Google Scholar
  • Pfaller, M.A., Andes, D., Arendrup, M.C., Diekema, D.J., Espinel-Ingroff, A., Alexander, B.D., Brown, S.D., Chaturvedi, V., Fowler, C.L., Ghannoum, M.A., Johnson, E.M., Knapp, C.C., Motyl, M.R., Ostrosky-Zeichner, L., Walsh, T.J.: Clinical breakpoints for voriconazole and Candida species revisited: Review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn Microbiol Infect Dis 70, 330–343 (2011).

    Walsh TJ , 'Clinical breakpoints for voriconazole and Candida species revisited: Review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria ' (2011 ) 70 Diagn Microbiol Infect Dis : 330 -343.

    • Search Google Scholar
  • Park, B.J., Arthington-Skaggs, B.A., Hajjeh, R.A., Iqbal, N., Ciblak, M.A., Lee-Yang, W., Hairston, M.D., Phelan, M., Plikaytis, B.D., Sofair, A.N., Harrison, L.H., Fridkin, S.K., Warnock, D.W.: Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome. Antimicrob Agents Chemother 50, 1287–1292 (2006).

    Warnock DW , 'Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome ' (2006 ) 50 Antimicrob Agents Chemother : 1287 -1292.

    • Search Google Scholar
  • Vella, A., De Carolis, E., Vaccaro, L., Posteraro, P., Perlin, D.S., Kostrzewa, M., Posteraro, B., Sanguinetti, M.: Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis. J Clin Microbiol 51, 2964–2969 (2013).

    Sanguinetti M , 'Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis ' (2013 ) 51 J Clin Microbiol : 2964 -2969.

    • Search Google Scholar
  • Vale-Silva, L.A., Pinto, P., Lopes, V., Ramos, H., Pinto, E.: Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp. Eur J Clin Microbiol Infect Dis 31, 941–946 (2012).

    Pinto E , 'Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp. ' (2012 ) 31 Eur J Clin Microbiol Infect Dis : 941 -946.

    • Search Google Scholar
  • Pfaller, M.A., Diekema, D.J.: Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J Clin Microbiol 50, 2846–2856 (2012).

    Diekema DJ , 'Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012 ' (2012 ) 50 J Clin Microbiol : 2846 -2856.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
submission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Aug 2021 7 0 0
Sep 2021 3 0 0
Oct 2021 7 0 0
Nov 2021 1 0 0
Dec 2021 9 0 0
Jan 2022 1 5 4
Feb 2022 0 0 0